Becton Dickinson & Co
BDXNYSECIK 10795HealthcareFiscal year ends Sep 30
Reports and events: 344 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-06-0717:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-029309 |
| 2024-06-0306:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-24-000044 |
| 2024-05-0216:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000010795-24-000039 |
| 2024-05-0206:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-24-000036 |
| 2024-02-2706:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-24-000024 |
| 2024-02-0816:19 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-006440 |
| 2024-02-0616:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-005880 |
| 2024-02-0116:35 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0000010795-24-000019 |
| 2024-02-0106:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-24-000015 |
| 2024-01-2616:34 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000010795-24-000006 |
| 2023-12-2116:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-23-000127 |
| 2023-12-1413:04 ET | DEF 14A | Proxy statementPeriod 2023-12-14 | 0000010795-23-000118 |
| 2023-11-2717:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000010795-23-000109 |
| 2023-11-2117:08 ET | 10-K | Annual reportPeriod 2023-09-30 | 0000010795-23-000098 |
| 2023-11-0906:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-23-000087 |
| 2023-09-2116:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000010795-23-000081 |
| 2023-08-0316:55 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000010795-23-000075 |
| 2023-08-0306:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-23-000072 |
| 2023-07-2416:53 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000010795-23-000060 |
| 2023-05-3107:09 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-23-027393 |
| 2023-05-0416:35 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000010795-23-000039 |
| 2023-05-0406:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-23-000038 |
| 2023-03-1006:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-23-010990 |
| 2023-02-1316:41 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-23-006356 |
| 2023-02-0709:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-004866 |
| 2023-02-0217:03 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0000010795-23-000030 |
| 2023-02-0206:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-23-000026 |
| 2023-01-3014:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000010795-23-000015 |
| 2023-01-2516:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-23-002734 |
| 2023-01-0606:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-23-000009 |
| 2022-12-1510:28 ET | DEF 14A | Proxy statementPeriod 2022-12-12 | 0000010795-22-000084 |
| 2022-11-2216:58 ET | 10-K | Annual reportPeriod 2022-09-30 | 0001628280-22-030686 |
| 2022-11-1006:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-029364 |
| 2022-09-2316:08 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000010795-22-000065 |
| 2022-08-2516:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-22-000059 |
| 2022-08-2217:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-030509 |
| 2022-08-2216:16 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-22-030495 |
| 2022-08-0916:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-028896 |
| 2022-08-0809:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-028573 |
| 2022-08-0412:58 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000010795-22-000052 |
| 2022-08-0406:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-22-000049 |
| 2022-05-3116:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-22-000042 |
| 2022-05-0511:57 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000010795-22-000040 |
| 2022-05-0506:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-22-000038 |
| 2022-04-1808:40 ET | 8-K | 8.01 Other events | 0001140361-22-014800 |
| 2022-04-1416:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-22-000031 |
| 2022-04-0617:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-097657 |
| 2022-03-3106:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-090652 |
| 2022-03-2116:17 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-080554 |
| 2022-03-0416:01 ET | 8-K | 5.04 Item not in the standard list | 0001193125-22-066046 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:43 ET. Listed shows no prices and gives no investment advice.